Results 171 to 180 of about 2,507 (209)
Some of the next articles are maybe not open access.

Pulmonary Delivery of Inhalable Nanoparticles: Dry Powder Inhalers

Therapeutic Delivery, 2011
Pulmonary administration of inhalable nanoparticles (NPs) is an emerging area of interest. Dry powder inhalers may offer particular advantages for pulmonary administration of NPs. This article reviews research performed on the formulation of inhalable NPs as dry powder to achieve deep-lung deposition and enhance NP redispersibility.
M H D Kamal, Al-Hallak   +5 more
openaire   +2 more sources

Pulmonary Distribution of an Inhaled Radioaerosol in Obstructive Pulmonary Disease

Radiology, 1976
Pulmonary distribution of an inhaled radioaerosol was analyzed in 20 cases of chronic obstructive pulmonary disease (COPD) and 8 of other OPD. Nonciliary/ciliary partition of the distribution correlated with the severity of airway obstruction and approximated 3:1 in mild and 1:3 in very severe obstruction.
M S, Lin, D A, Goodwin
openaire   +2 more sources

Inhalational Drug Delivery in Pulmonary Aspergillosis

Critical Reviews™ in Therapeutic Drug Carrier Systems, 2019
Pulmonary infections have long represented one of the major threats to humans. These vary from acute to chronic conditions, depending upon the underlying disease of the airways. Pulmonary aspergillosis (PMAP) has raised vital concerns in the immunocompromised patients.
Ranjot, Kaur   +6 more
openaire   +2 more sources

Inhaled prostacyclin in the treatment of pulmonary hypertension

European Journal of Pediatrics, 1999
Pulmonary hypertension can occur primarily with an unknown aetiology or secondary in association with cardiac or pulmonary disorders such as congenital diaphragmatic hernia, idiopathic respiratory distress syndrome, acute respiratory distress syndrome (ARDS), congenital heart disease with malformation of the pulmonary blood vessels, chronic obstructive
M, Max, R, Rossaint
openaire   +2 more sources

INHALATION PULMONARY SCINTIPHOTOGRAPHY USING PERTECHNETATE

American Journal of Roentgenology, 1971
Inhalation lung scintiphotos of good quality with a minimum of bronchial deposition have been obtained using a simple, inexpensive nebulizing system and technetium in the pertechnetate form.The method described is a rapid means of obtaining useful information regarding airway patency with no radiopharmaceutical preparation.Pertechnetate is a suitable ...
D J, Cook, H, Lander
openaire   +2 more sources

Inhalation of Ethyl Alcohol for Pulmonary Edema

New England Journal of Medicine, 1951
TREATMENT of experimental pulmonary edema with ethyl alcohol as an antifoaming agent has been described by Luisada.1 However, no clinical experience with this agent has as yet appeared in the liter...
A, GOOTNICK, H I, LIPSON, J, TURBIN
openaire   +2 more sources

Pulmonary effects of inhaled cannabis smoke

The American Journal of Drug and Alcohol Abuse, 2019
Background: The smoke generated from cannabis delivers biologically active cannabinoids and a number of combustion-derived toxins, both of which raise questions regarding the impact of cannabis smoking on lung function, airway inflammation and smoking-related lung disease.Objectives: Review the potential effects of cannabis smoking on respiratory ...
Donald P. Tashkin, Michael D. Roth
openaire   +2 more sources

Age, Smoking Inhalation, and Pulmonary Function

Archives of Environmental Health: An International Journal, 1975
This study examined the relative effects of age and smoking on pulmonary function. Smoking was measured by six smoking variables, taken singly and as a composite. Subjects were 1,516 male participants in the Normative Aging Study. A stepwise multiple regression with vital capacity (VC) and forced expiratory volume at one second (FEV1.0) as the criteria
R, Bossé   +3 more
openaire   +2 more sources

Pulmonary Inhalation Injury

1995
The toxic effects of inhaling smoke were first documented following the Cleveland Clinic disaster in Ohio on 15 May 1929 and later after the Coconut Grove Nightclub Fire in Boston on 28 November 1942.
openaire   +1 more source

Pulmonary toxicity of inhaled and intravenous talc

Toxicology Letters, 1990
Talc (magnesium silicate) is a widely used, generally considered benign substance. It is principally used as an inert filler material in drug tablets or as a drying ingredient in baby powders. However, in both cases inappropriate use can lead to severe pulmonary toxicological responses.
openaire   +2 more sources

Home - About - Disclaimer - Privacy